Inhibition of Ceramide Metabolism Sensitizes Human Leukemia Cells

Tag: 153436-53-4

The relative non-toxicity from the diuretic amiloride, in conjunction with its selective inhibition from the protease urokinase plasminogen activator (uPA), makes this substance course attractive for structure-activity research. plasminogen activation (uPA) pathways are made up of urokinase-type plasminogen activator (uPA), its plasmalemmal receptor (uPAR), and extracellular plasminogen. uPA can be synthesized intracellularly as an individual …Read More